Exponent, Inc. reported a robust fourth quarter and fiscal year 2024, with total revenues increasing by 11.3% to $136.8 million in Q4 and 4.1% to $558.5 million for the full year. Net income also saw significant growth, reaching $23.6 million in Q4 and $109.0 million for the fiscal year, driven by strong demand across various industries and improved operational efficiency.
Fourth quarter total revenues increased 11.3% to $136.8 million, exceeding expectations.
Net income for Q4 rose to $23.6 million, or $0.46 per diluted share, compared to $20.9 million, or $0.41 per diluted share in the prior year.
EBITDA increased to $31.2 million in Q4, representing 25.2% of revenues before reimbursements.
For the full fiscal year 2024, total revenues increased 4.1% to $558.5 million, and net income reached $109.0 million.
For the first quarter of fiscal 2025, Exponent anticipates revenues before reimbursements to be slightly down in the low-single digits, with EBITDA expected to be between 25.0% and 26.0% of revenues before reimbursements. For the full fiscal year 2025, the company expects revenues before reimbursements to grow in the low-single digits, and EBITDA to be between 26.25% and 27.0% of revenues before reimbursements.